Skip to main content

Table 1 Clinical data of investigated patients, DPYD genotype and number of clones sequenced per patient.

From: Hypermethylation of the DPYD promoter region is not a major predictor of severe toxicity in 5-fluorouracil based chemotherapy

     

Toxicity grade

 

N clones

 

Sex

Age

Tumor

Regimen

hematologic

gastrointestinal

dermatologic

DPYD genotype (coding region/splice sites)

Total

Methylated

Patients with severe 5-FU related toxicity

1

m

53

Gastric

5FU-FA

1

3

0

-

21

0

2

f

70

Breast

CAPE

0

3

0

c.85T>C, C29R; c.496A>G, M166V

20

0

3

f

55

Gastric

CAPE-P

3

0

0

c.1601G>A, S534N

21

0

4

m

74

Colon

5FU-FA-P

4

4

0

-

20

0

5

f

53

Colon

5FU-FA-P

3

1

0

c.496A>G, M166V

21

0

6

m

66

Tonsil

5FU-P

2

3

3

c.85T>C, C29R; 1236G>A, E412E

20

0

7

m

53

Oesophagus

5FU-P

4

4

0

-

20

0

8

f

54

Breast

E-5FU-C

3

1

0

1627A>G, I543V

21

0

9

f

65

Gastric

E-5FU-P

3

1

2

-

22

0

10

m

79

Oesophagus

5FU-P

2

3

0

c.85T>C, C29R; c.1236G>A, E412E

20

0

11

f

67

Rectum

5FU-P

4

4

0

c.496A>G, M166V

22

0

12

f

57

Gastric

E-5FU-P

3

1

0

c.85T>C, C29R; c.1236G>A, E412E; c.1627A>G, I543V

20

0

13

m

57

Rectum

5FU

3

0

0

1896T>C, F632F

21

0

14

m

67

unknowna

5FU-IRI

3

0

0

c.85T>C, C29R; c.1627A>G, I543V

24

0

15

f

50

Rectum

5FU-FA-P

1

3

0

c.85T>C, C29R

25

0

16

m

75

Gastric

5FU

2

3

0

-

21

0

17

f

47

Breast

CAPE

1

1

3

c.85T>C, C29R; c.496A>G, M166V

30

0

Control patients

18

f

72

Rectum

5FU

1

1

0

-

20

0

19

f

54

Gastric

5FU-FA-P

2

1

0

c.1679T>G, I560S

21

0

20

m

59

Pancreas

5FU-FA-P

0

1

0

c.85T>C, C29R; c.1627A>G, I543V(H)

20

0

21

m

62

Colon

5FU-FA-P

0

1

0

c.85T>C, C29R (H); c.496A>G, M166V, c.1236G>A, E412E

19

0

22

f

64

Colon

5FU-FA

0

0

0

c.85T>C, C29R; c.1627A>G, I543V

20

0

23

m

63

Oesophagus

5FU-P

1

0

0

-

20

0

24

f

69

Colon

5FU-FA

0

1

0

c.85T>C, C29R (H); c.496A>G, M166V; c.2194G>A, V732I

20

0

25

m

59

Gastric

5FU-FA

1

1

0

c.85T>C, C29R; c.1627A>G, I543V; 1896T>C, F632F

21

0

26

m

59

Colon

5FU-FA-P

1

1

0

c.85T>C, C29R (H); c.496A>G, M166V; c.1627A>G, I543V

20

0

27

m

62

Gastric

E-CAPE-P

2

1

2

c.85T>C, C29R (H); c.496A>G, M166V; c.1236G>A, E412E c.1627A>G, I543V

30

0

  1. Abbreviations: FA, folinic acid; CAPE, capecitabine; P, platinum compound; E, epirubicin; C, cyclophosphamide; H, homozygous carrier a adenocarcinoma of unknown origin